癌症患者的心房动:流行病学,鉴定和管理
Chengqi Yu1, Leilei Jiang2, Liuhua Long2
1National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Seminars in cancer biology
|February 24, 2025
概括
心房动 (AF) 是癌症患者日益关注的问题,增加心血管风险. 早期检测和干预对于改善瘤患者的生存率至关重要,尽管原因和治疗需要进一步研究.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 癌症和心血管疾病 (CVD) 是全球主要的死亡原因,并增加了相关疾病.
- 心房动 (AF) 是瘤患者常见的与癌症相关的心血管毒性 (CTR-CVT),对健康造成重大风险.
- 人口老龄化和改进的癌症疗法有助于同时存在的疾病的发病率上升.
研究的目的:
- 审查目前关于瘤病人的心房动 (AF) 的研究.
- 要总结流行病学,病理生理机制,诊断和治疗癌症患者的AF.
- 确定研究缺口,并提出临床反应的未来方向.
主要方法:
- 系统审查和整合现有指南和研究.
- 对瘤学患者的AF当前研究的分析.
- 综合有关流行病学,机制,诊断和治疗的信息.
主要成果:
- 心房动 (AF) 对瘤病患者构成重大威胁,可能导致进一步的心血管并发症.
- 癌症患者的AF最佳治疗策略和因果机制尚不清楚.
- 早期检测和干预对于癌症幸存者的长期生存至关重要.
结论:
- 需要进一步的研究来阐明机制,并在瘤学患者中确定AF的最佳治疗方法.
- 在癌症患者中全面了解AF对于改善临床管理和患者结果至关重要.
- 本综述提供了一个综合的概述,以帮助临床医生在癌症护理中解决AF问题.
相关概念视频
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Increased pulse rate
635
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
635
Disturbances in Heart Rhythm
866
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
866
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
128
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
128
Cancer Survival Analysis
320
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
320

